Fang Zhou

机构：Shandong University of Traditional Chinese Medicine, University of Electronic Science and Technology of China, China Pharmaceutical University, Wuhan University, Zhengzhou University, Wuhan Puai Hospital, People's Liberation Army 401 Hospital, Renmin Hospital of Wuhan University, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, State Key Laboratory of Natural Medicine, Arizona State University, Southern Medical University · ORCID：0000-0002-8271-4116

发表论文 114 篇 · 总被引 2718 次 · h-index 33

代表论文

• PGC-1α-mediated imbalance of mitochondria-lipid droplet homeostasis in neomycin-induced ototoxicity and nephrotoxicity (2024 · Acta Pharmaceutica Sinica B · 被引 37)
• Mitochondrial Regulation of Ferroptosis in Cancer Cells (2025 · International Journal of Biological Sciences · 被引 25)
• Improved pharmacokinetics of tenofovir ester prodrugs strengthened the inhibition of HBV replication and the rebalance of hepatocellular metabolism in preclinical models (2022 · Frontiers in Pharmacology · 被引 23)
• Renal remodeling by CXCL10-CXCR3 axis-recruited mesenchymal stem cells and subsequent IL4I1 secretion in lupus nephritis (2024 · Signal Transduction and Targeted Therapy · 被引 18)
• Engineered MSCs Break Endothelial‐Myofibroblast Crosstalk in Pulmonary Fibrosis: Reconstructing the Vascular Niche (2025 · Advanced Materials · 被引 17)
• Magnesium Isoglycyrrhizinate Reduces the Target-Binding Amount of Cisplatin to Mitochondrial DNA and Renal Injury through SIRT3 (2022 · International Journal of Molecular Sciences · 被引 17)